Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients

NCT01393795 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Hypertension
Pain

Interventions

DRUG: Qutenza
DRUG: Tegaderm

Sponsor

Imperial College London

Collaborators

[object Object]